VivoSim Labs, Inc.: 10-Q filed 2011-10-31

Name: VivoSim Labs, Inc.: 10-Q filed 2011-10-31
Creator: VivoSim Labs, Inc.

What VivoSim Labs, Inc. reported in its quarterly report filed 2011-10-31 (fiscal Q1 2012): 17 published measures, 51 facts as tagged in accession 0001213900-11-005689.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-10-31
Fiscal period: fiscal Q1 2012
Accession: 0001213900-11-005689 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VivoSim Labs, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	3,628	USD
At 2011-06-30	4,275	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-09-30	32,190	USD
At 2011-06-30	10,692	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	1,128	USD
At 2011-06-30	1,775	USD
At 2010-09-30	88,975	USD
At 2010-06-30	141,125	USD
At 2009-12-14	0	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-647	USD	92
2009-12-15 to 2011-09-30	-139,797	USD	655
2010-07-01 to 2010-09-30	-22,225	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	1,677	USD	92
2009-12-15 to 2011-09-30	1,677	USD	655
2010-07-01 to 2010-09-30	0	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	0	USD	92
2009-12-15 to 2011-09-30	170,925	USD	655
2010-07-01 to 2010-09-30	75	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	0	USD	92
2009-12-15 to 2011-09-30	-30,000	USD	655
2010-07-01 to 2010-09-30	-30,000	USD	92

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2011-07-01 to 2011-09-30	USD	92
2009-12-15 to 2011-09-30	USD	655
2010-07-01 to 2010-09-30	USD	92

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-09-30	28,868	USD
At 2011-06-30	10,692	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	25,122	USD	92
2009-12-15 to 2011-09-30	210,864	USD	655
2010-07-01 to 2010-09-30	25,721	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-09-30	6,802,500	shares
At 2011-06-30	6,802,500	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-09-30	179,945	USD
At 2011-06-30	178,645	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2011-09-30	-28,562	USD
At 2011-06-30	-6,417	USD
At 2010-06-30	136,125	USD
At 2009-12-14	0	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-23,445	USD	92
2009-12-15 to 2011-09-30	-209,187	USD	655
2010-07-01 to 2011-06-30	-147,817	USD	365
2010-07-01 to 2010-09-30	-25,721	USD	92
2009-12-15 to 2010-06-30	-37,925	USD	198

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	2,622	USD	92
2009-12-15 to 2011-09-30	37,236	USD	655
2010-07-01 to 2010-09-30	1,889	USD	92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	0	USD	92
2009-12-15 to 2011-09-30	2,277	USD	655
2010-07-01 to 2010-09-30	49	USD	92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	0	USD	92
2009-12-15 to 2011-09-30	170,925	USD	655
2010-07-01 to 2010-09-30	75	USD	92

Inspect the source

Entity: VivoSim Labs, Inc. / CIK 0001497253
Captured: 2026-09-20T09:11:03.612Z
SEC response SHA-256: c9ff312a652cbde719fdab7c214ee08503323ac8b24c6a7d9a70ff61471feb23

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001497253.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))